BeyondSpring Inc. Payments to Acquire Short-term Investments
BeyondSpring Inc. (BYSI) reported Payments to Acquire Short-term Investments of $22.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-14
- BeyondSpring Inc. payments to acquire short-term investments for the quarter ending 2026-06-30 was $15.01M, a 650.25% increase year-over-year.
- BeyondSpring Inc. payments to acquire short-term investments for the quarter ending 2026-03-31 was $7.16M, a 138.70% increase year-over-year.
- BeyondSpring Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $7.71M, a 28.55% decline year-over-year.
- BeyondSpring Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was $2.24M, a 12.05% increase year-over-year.
- BeyondSpring Inc. payments to acquire short-term investments for fiscal 2025 was $14.95M, a 16.90% increase from fiscal 2024.
- BeyondSpring Inc. payments to acquire short-term investments for fiscal 2024 was $12.79M, a 883.69% increase from fiscal 2023.
- BeyondSpring Inc. payments to acquire short-term investments for fiscal 2023 was $1.30M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $22.17M 10-Q · filed 2026-08-14 | $29.87M derived: sum of 3 quarters · filed 2026-08-14 | $32.12M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $7.16M 10-Q · filed 2026-05-13 | $14.87M derived: sum of 2 quarters · filed 2026-05-13 | $17.11M derived: sum of 3 quarters · filed 2026-05-13 | $19.11M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $9.95M derived: sum of 2 quarters · filed 2026-03-25 | $11.95M derived: sum of 3 quarters · filed 2026-08-14 | $14.95M 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.24M derived: sum of 2 quarters · filed 2026-08-14 | $7.24M 10-Q · filed 2025-11-12 | $18.03M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $5.00M 10-Q · filed 2026-08-14 | $15.79M derived: sum of 3 quarters · filed 2026-08-14 | $17.79M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $3.00M 10-Q · filed 2026-05-13 | $13.79M derived: sum of 2 quarters · filed 2026-05-13 | $15.79M derived: sum of 3 quarters · filed 2026-05-13 | $15.79M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $12.79M derived: sum of 2 quarters · filed 2026-03-25 | $12.79M derived: sum of 3 quarters · filed 2026-03-25 | $12.79M 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.00M derived: sum of 2 quarters · filed 2025-11-12 | $2.00M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $1.30M 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $32.20M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $28.59M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $19.23M derived: sum of 2 quarters · filed 2023-04-18 | $44.23M 20-F · filed 2023-04-18 | |
| 2021-09-30 | -$9.36M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $15.64M 6-K · filed 2021-12-30 | ||
| 2021-06-30 | $25.00M 6-K · filed 2021-09-10 | |||
| 2020-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $0.00 derived: sum of 2 quarters · filed 2023-04-18 | $0.00 20-F · filed 2023-04-18 | |
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $0.00 6-K · filed 2021-12-30 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-09-10 | |||
| 2019-12-31 | $0.00 20-F · filed 2022-04-14 | |||
| 2017-12-31 | $68.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $3.07M 20-F · filed 2020-04-30 | ||
| 2017-09-30 | $3.01M 6-K · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |